Wheeler Bio appoints industry veteran Patrick Lucy as Chief Executive Officer
Patrick joins Wheeler with more than 32 years of extensive experience in the biotechnology industry.
OKC’s pro soccer club to undergo community driven brand review
Process will involve regular listening sessions and consideration of a women’s team in the future
Seasoned sports industry veteran Court Jeske joins Echo
Jeske brings impressive track record of MLS and USL leadership roles and global soccer experience to Echo’s growing portfolio of rapidly emerging sports & entertainment investments
Antheia announces new funding to support domestic production of critical pharmaceutical ingredients
Company awarded government project agreement to onshore key pharmaceutical supply chains, alongside strategic investment from In-Q-Tel and Echo
Echo joins Energy FC as majority owner of Oklahoma City’s professional soccer club
The expanded ownership group is poised to elevate the club to new heights in the coming years.
Echo announces landmark sale of mineral and royalty interests in Permian and Anadarko basins
Echo announced a major milestone with completion of an asset sale by its affiliate Echo Minerals totaling more than half a billion dollars. The transaction with Sixth Street Partners involved the sale of a portion of Echo’s net royalty acres in the Permian and Anadarko basins.
Echo Impact launches to empower underrepresented communities, unlock innovation in OKC’s ongoing renaissance
Echo, a multi-strategy investment firm founded by Christian Kanady in 2010, announced the formal launch of Echo Impact to be led by seasoned community developer Sandino Thompson. The investment strategy is anchored on the philosophy that social and financial returns can and should be intertwined.
Charles River and Wheeler Bio complete agreement to accelerate the journey from discovery and CMC development to manufacturing
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry, Manufacturing and Controls) platform.
TARA Mind announces $8 million in seed funding to expand affordable access to life-changing mental health therapeutics
TARA Mind, a public benefit corporation focused on creating access to safe and effective ketamine-assisted therapy (KAT) as a covered benefit for employees, announced today that the Company has raised $8 million, led by Satori Neuro. Additional investors participating in the oversubscribed round were Echo Investment Capital, Crumpton Ventures, Empath Ventures, and Blake Mykoskie: Founder of TOMS.
Nucleus RadioPharma secures $56 million Series A funding to expand production of radiopharmaceutical treatments for cancer patients
Co-led by Eclipse and GE HealthCare, the investment will accelerate research, streamline supply chains, and make targeted radiopharmaceutical therapies accessible.